Efficacy of the Cardiac Rehabilitation Program in Patients with End-Stage Heart Failure, Heart Transplant Patients, and Left Ventricular Assist Device Recipients

被引:61
|
作者
Karapolat, H. [1 ]
Engin, C. [2 ]
Eroglu, M. [1 ]
Yagdi, T. [2 ]
Zoghi, M. [2 ]
Nalbantgil, S. [2 ]
Durmaz, B. [1 ]
Kirazli, Y. [1 ]
Ozbaran, M. [2 ]
机构
[1] Ege Univ, Phys Med & Rehabil Dept, TR-35100 Izmir, Turkey
[2] Ege Univ, Dept Cardiac Surg, TR-35100 Izmir, Turkey
关键词
QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; TIME-COURSE; METAANALYSIS; TRIAL;
D O I
10.1016/j.transproceed.2013.06.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. The objective of this study was to assess the effects of cardiac rehabilitation on the functional capacity, pulmonary functions, quality of life, and psychological state of patients who had heart failure (HF), heart transplantation (HTx), or a left ventricular assist device (LVAD). Methods. An 8-week exercise program was undertaken by 46 patients diagnosed with end-stage heart failure, 40 of whom had a heart transplantation and 11 were implanted with an LVAD. The patients' functionality was assessed with a maximal oxygen consumption test (pVO(2)), their psychological state with the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI), their quality of life (QOL) with the Short Form 36 (SF 36), and their pulmonary condition with pulmonary function tests (PFTs). Results. A significant improvement was observed in all forced vital capacity (%), forced expiratory volume in 1 second (%), pVO(2), BDI, and most of the subscores of the SF 36 scores at the end of the exercise, compared with the pre-exercise period (P <.05). The intergroup evaluations showed no significant differences among the 3 groups in terms of all assessed changes (F>.05). Conclusion. An 8-week supervised exercise program was observed to improve functional capacity, PFT, QOL, and depression among patients who had HF, HTx, or LVAD. Supervised exercise should be recommended for every patient included in a heart transplant program.
引用
收藏
页码:3381 / 3385
页数:5
相关论文
共 50 条
  • [41] Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension
    Nair, Pradeep K.
    Kormos, Robert L.
    Teuteberg, Jeffrey J.
    Mathier, Michael A.
    Bermudez, Christian A.
    Toyoda, Yoshiya
    Dew, Mary Amanda
    Simon, Marc A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : 201 - 208
  • [42] Why do left ventricular assist device recipients remain heart failure patients?
    Loardi, Claudia
    Zanobini, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (06) : 1054 - 1055
  • [43] A Novel Percutaneons Right Ventricular Assist Device for End-stage Heart Failure
    Takayama, Hiroo
    Naka, Yoshifumi
    Kodali, Susheel K.
    Vincent, Julie A.
    Addonizio, Linda J.
    Jorde, Ulrich P.
    Williams, Mathew R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B71 - B71
  • [44] Left ventricular assist devices as destination therapy for end-stage heart failure
    Yager, JEE
    Felker, GM
    AMERICAN HEART JOURNAL, 2004, 148 (02) : 252 - 253
  • [45] Left ventricular assist devices as destination therapy for end-stage heart failure
    Stevenson L.W.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (6) : 471 - 479
  • [46] Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation -: An outlook for permanent assisting?
    de Jonge, N
    Kirkels, H
    Lahpor, JR
    Klöpping, C
    Hulzebos, EJ
    de la Rivière, AB
    de Medina, EOR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 1794 - 1799
  • [47] Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
    Mullan, Clancy
    Caraballo, Cesar
    Ravindra, Neal G.
    Miller, P. Elliott
    McCullough, Megan
    Brown, Kelly
    Aw, Tsung Wai
    Gruen, Jadry
    Clarke, John-Ross D.
    Velazquez, Eric J.
    Geirsson, Arnar
    Mori, Makoto
    Desai, Nihar R.
    Ahmad, Tariq
    JACC-HEART FAILURE, 2020, 8 (07) : 569 - 577
  • [48] IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE - APPROACHING AN ALTERNATIVE FOR END-STAGE HEART-FAILURE
    MCCARTHY, PM
    JAMES, KB
    SAVAGE, RM
    VARGO, R
    KENDALL, K
    HARASAKI, H
    HOBBS, RE
    PASHKOW, FJ
    CIRCULATION, 1994, 90 (05) : 83 - 86
  • [49] IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE - APPROACHING AN ALTERNATIVE FOR END-STAGE HEART-FAILURE
    MCARTHY, PM
    JAMES, K
    SAVAGE, R
    BRAVO, EL
    VARGO, R
    HARASAKI, H
    PASHKOW, F
    CIRCULATION, 1993, 88 (04) : 286 - 286
  • [50] Metabolomic and Gene Expression Changes in End-Stage Heart Failure are Reversed by Left Ventricular Assist Device
    Gupte, Anisha
    Hamilton, Dale J.
    Cordero-Reyes, Andrea M.
    Youker, Keith A.
    Loebe, Matthias
    Stevens, Robert D.
    Wenner, Brett
    Ilkayeva, Olga
    Taegtmeyer, Heinrich
    Newgard, Christopher B.
    Torre-Amione, Guillermo
    Hsueh, Willa A.
    CIRCULATION, 2012, 126 (21)